OHSU Doernbecher awarded $3 million to advance tuberculosis vaccine research
December 07, 2015
Project to expand on previous OHSU breakthroughs in cell and immune system discovery
Stories
New leads in the struggle against a formidable leukemia
December 04, 2015
A coordinated push to decrypt a complex form of leukemia is delivering a trove of new drug candidates and treatment ideas, a dozen of which will be presented at the American Society of Hematology Annual Meeting in Orlando, Florida (Dec. 5-8).
OHSU Knight Cancer Institute awards funding to 13 community health projects statewide
November 30, 2015
Funded projects ― which range from identifying barriers Oregonians face in quitting tobacco use to an after-school physical activity program for youth in rural communities ― are geared toward decreasing the state’s cancer burden
OHSU and Moda agree to option to convert note to equity
November 17, 2015
With a goal of improving the health of Oregonians, Oregon Health & Science University and Moda Health Plan, Inc. have signed a nonbinding letter of intent to create a joint board and provide OHSU an optin to acquire a 25 percent equity position in Moda Health by converting a $50 million surplus note.
Oregon Health & Science University and Salem Health affiliation officially launches
November 10, 2015
Oregon Health & Science University and Salem Health have finalized an agreement to manage their respective clinical services as an integrated health system. The agreement creates OHSU Partners, a joint management company that will officially become operational on Monday, Nov. 16.
What really makes cancer drug ‘super responders’ exceptional survival stories?
November 09, 2015
Reports of “super responders” – patients who do exceptionally well on a cancer treatment –may be driving unfounded assumptions about the effectiveness of the drugs involved, researchers caution.
OHSU statement regarding its investment in health care transformation
November 06, 2015
$50 million surplus note supports participation in health care exchange
Kidney cancer’s genomic drivers revealed
November 04, 2015
A massive search involving cancer researchers across the U.S. and Canada has revealed many of the altered genes and cell signaling pathways that drive a poorly understood form of kidney cancer, primary papillary renal cell carcinoma.
Bay Area Cancer Center first to join OHSU Knight Cancer Network
October 31, 2015
Bay Area Hospital and the OHSU Knight Cancer Institute have agreed to launch the first site of the newly formed OHSU Knight Cancer Network at the Bay Area Cancer Center in Coos Bay, Oregon.
